InsiderClue
Insiders · Profile

Wysenski Nancy

Director at Alkermes · EVP, Chief Commercial Officer at Vertex Pharmaceuticals. Filing since 15 Nov 2011. CIK 0001294596

ALKS Alkermes plc. Director · 4 trades VRTX Vertex Pharmaceuticals EVP, Chief Commercial Officer · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ALKS Alkermes plc.
9 May 2023
Director
Sold on a plan
41,250
$1.29M
72.3%
ALKS Alkermes plc.
24 Feb 2020
Director
Bought
6,940
$136.37K
161%
ALKS Alkermes plc.
14 Mar 2019
Director
Bought
445
$14.71K
11.5%
ALKS Alkermes plc.
21 Feb 2019
Director
Bought
3,857
$127.63K
opened
VRTX Vertex Pharmaceuticals
14 May 2012
EVP, Chief Commercial Officer
Sold, plan not stated
180,000
$11.57M
84.8%
VRTX Vertex Pharmaceuticals
8 May 2012
EVP, Chief Commercial Officer
Sold, plan not stated
38,009
$2.36M
54.8%
VRTX Vertex Pharmaceuticals
7 May 2012
EVP, Chief Commercial Officer
Sold, plan not stated
147,695
$8.05M
82.5%
VRTX Vertex Pharmaceuticals
19 Jan 2012
EVP, Chief Commercial Officer
Sold, plan not stated
6,042
$223.55K
21.6%
VRTX Vertex Pharmaceuticals
12 Dec 2011
EVP, Chief Commercial Officer
Sold, plan not stated
5,000
$144.50K
15.2%
VRTX Vertex Pharmaceuticals
15 Nov 2011
EVP, Chief Commercial Officer
Sold, plan not stated
606
$18.04K
1.8%
10 decisions on file.